Dechra Brings Globally Trusted Domidine™ (detomidine hydrochloride) to the U.S. Equine Market
Dechra, a global leader in veterinary specialty care, today announced the U.S. launch of Domidine™ (detomidine hydrochloride), a trusted, effective equine sedative and analgesic for facilitating minor surgical and diagnostic procedures in horses.1-3
Dechra Announces FDA Approval of Emeprev™ (maropitant citrate) Injectable Solution
Dechra, a global leader in veterinary specialty care, today shares the FDA approval of Emeprev™ (maropitant citrate) Injectable Solution, the first FDA-approved bioequivalent injectable solution to the most widely used antiemetic for dogs and cats.1
Dechra Advances Public Health as Newest Human-Animal Bond Certified Company
Dechra, a global leader in veterinary specialty care, announced today its status as the newest Human-Animal Bond Certified Company. As a Human-Animal Bond Certified Company, Dechra has made a major commitment to supporting human-animal bond education for veterinary professionals, to training its own workforce on the science of the bond, and to supporting the research efforts of the Human-Animal Bond Research Institute (HABRI).
